|
Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer Clinical research trials and Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer. Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer clinical trial. Subjects frequently get the best healthcare possible for their Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer  Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
For Condition: Prostatic Neoplasms
Status: No longer recruiting
Sponsor(s): TAP Pharmaceutical Products ,
Synopsis: The primary purpose of the study is to determine if a new sustained-release (depot) formulation of leuprolide, known as Lupron Depot-6 Month, will lower the amount of testosterone (male hormone) in the blood for a period of six months. The way in which the drug, leuprolide, is released from the depot during this time period will also be studied as well as the effect on a marker of prostate cancer known as PSA. The safety of the new formulation will also be studied.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: - Histological diagnosis of prostate cancer - Need for androgen deprivation treatment for 1 year - Discontinuation from other prostate cancer treatments
Total Enrollment:
Location and Contact Information:
Florida Foundation for Healthcare Research
Ocala, Florida, 34474
United States
206 Research Associates
Greenbelt, Maryland, 20770
United States
Medical Affiliated Research Center
Huntsville, Alabama, 35801
United States
Los Angeles Clinical Research Center
Encino, California, 91416
United States
Lawrenceville Urology
Lawrenceville, New Jersey, 08648
United States
Urological Surgeons of Long Island
Garden City, New York, 11530
United States
Center for Urologic Research
La Mesa, California, 91942
United States
Urological Associates, PC
Davenport, Iowa, 52807
United States
Kankakee Urological Associates
Kankakee, Illinois, 60901
United States
Vanderbilt Medical Center Dept of Urologic Surgery
Nashville, Tennessee, 37232
United States
Georgia Urology, PA
Atlanta, Georgia, 30342
United States
UroSearch
Inverness, Florida, 34452
United States
Alaska Clinical Research Center, LLC
Anchorage, Alaska, 99508
United States
Center for Urologic Research of Western New York
Williamsville, New York, 14221
United States
University Urological Research Institute
Providence, Rhode Island, 02906
United States
West Side Veteran Administration Medical Center
Chicago, Illinois, 60602
United States
Advanced Research Institute
New Port Richey, Florida, 34652
United States
Atlantic Urological Associates
St. Augustine, Florida, 32086
United States
Sheldon J. Freedman, MD, LTD
Las Vegas, Nevada, 89109
United States
Emory University
Atlanta, Georgia, 30322
United States
Lawrenceville Urology
St. Joseph, Michigan, 49085
United States
Salt Lake Research
Salt Lake City, Utah, 84124
United States
Hudson Valley Urology
Poughkeepsie, New York, 12601
United States
Madigan Army Medical Center
Tacoma, Washington, 98431
United States
South Orange County Medical Research Center
Laguna Woods, California, 92653
United States
Urology Research Options
Aurora, Colorado, 80012
United States
Associated Urologic Specialists, PA
Marlton, New Jersey, 08053
United States
Urology Specialists & Associates
Dallas, Texas, 75231
United States
Urology Associates of North Texas
Ft. Worth, Texas, 76104
United States
Atlantic Urological Associates
New Smyrna Beach, Florida, 32168
United States
Devine-Tidewater Urology
Virginia Beach, Virginia, 23454
United States
Nevada Urology Associates
Reno, Nevada, 89511
United States
Northeast Indiana Research
Ft. Wayne, Indiana, 46825
United States
Atlantic Urological Associates
Orange City, Florida, 32763
United States
Urological Surgical Associates
Edison, New Jersey, 08837
United States
Grand Strand Urology
Myrtle Beach, South Carolina, 29572
United States
Atlantic Urological Associates
Daytona Beach, Florida, 32114
United States
Specialty Care Research
Peoria, Illinois, 61614
United States
Welborn Clinic East
Evansville, Indiana, 47713
United States
Urology Associates of Central California
Fresno, California, 93720
United States
Urology San Antonio Research
San Antonio, Texas, 78229
United States
Northeast Urology Research
Concord, North Carolina, 28025
United States
Urology Centers of Alabama
Homewood, Alabama, 35209
United States
Kansas City Urology Care
Kansas City, Missouri, 64111
United States
Saint Louis Urological Surgeons, Inc
St. Louis, Missouri, 63136
United States
Western Clinical Research
Torrance, California, 90505
United States
UroSearch
Ocala, Florida, 34470
United States
Urology of Indiana, LLC
Indianapolis, Indiana, 46202
United States
Connecticut Clinical Research Center
Waterbury, Connecticut, 06708
United States
Suffolk Urology Associates
Bay Shore, New York, 11706
United States
San Diego Uro-Research
San Diego, California, 92101
United States
The Urology Group
Cincinnati, Ohio, 45212
United States
Pacific Clinical Center
Encino, California, 91316
United States
Visions Clinical Research
Palm Springs, Florida, 33461
United States
Arkansas Urology
Little Rock, Arkansas, 72211
United States
South Florida Medical Research
Aventura, Florida, 33180
United States
Additional Information:
Study ID Numbers: C02-008;
Study Start Date: March 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00056654
Other Prostatic Neoplasms Studies:
1. Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment
2. Comparison PSA Vaccine Alone or Vaccine with Docetaxel for Treating Prostate Cancer
3. A Phase III, Randomized Study of Atrasentan in Men with Non-Metastatic, Hormone-Refractory Prostate Cancer
4. YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
5. Safety and Efficacy of Atrasentan in Men with Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Related Studies:
Other Prostatic Neoplasms Clinical Trials
Other Missouri Clinical Trials
Other Kansas City Clinical Trials
Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
|
|
|
|
|
|
|
|
